Government-Led Bio Workforce Center Is the World’s Third
Incheon Free Economic Zone Authority: "Aiming to Become a Global Bio Innovation Hub"

A facility dedicated to training professionals for the bioindustry has opened in Songdo International City, Incheon, which boasts the world’s largest biopharmaceutical production capacity.


The Incheon Free Economic Zone Authority announced on the 25th that it would hold an opening ceremony for the Bio Process Workforce Training Center at Yonsei University’s International Campus in Songdo.


The center covers an area of 6,600 square meters and is equipped with advanced training facilities that meet GMP (Good Manufacturing Practice) standards, as well as a state-of-the-art bio process education system. It is expected to produce 2,000 bioindustry professionals annually.


The facility will be operated and managed by the Incheon Metropolitan Government, the Incheon Free Economic Zone Authority, and Incheon Technopark. Yonsei University will lead the development of the training curriculum, offering master’s degree programs and customized courses for both current employees and job seekers, in order to quickly foster practical bioindustry talent that meets on-site demand.


The Incheon Free Economic Zone Authority expects that by producing tailored talent for the bioindustry, the center will generate jobs, help the bio cluster advance, revitalize the industry-academia-research ecosystem, and create a virtuous cycle that includes expanding into global markets.


Bio Process Workforce Training Center. Incheon Free Economic Zone Authority

Bio Process Workforce Training Center. Incheon Free Economic Zone Authority

View original image

The establishment of the Bio Process Workforce Training Center under government leadership marks the third such case in the world, following Ireland and the United States. Going forward, Incheon plans to link its regional bio-related infrastructure with global bio companies such as Samsung Biologics and Celltrion, as well as local hospitals, research institutes, and universities, to discover a variety of collaborative projects between industry, academia, and research sectors.


Since last year, the Incheon Free Economic Zone Authority has been collaborating with the World Health Organization (WHO) and the Ministry of Health and Welfare to provide basic training on global vaccine and biopharmaceutical production processes. Incheon is also home to a cluster of bio workforce training infrastructure, including the Yonsei University K-NIBRT (Korean National Institute for Bioprocessing Research and Training) Training Center, Incheon National University Bio Convergence ICC Center (Industry Collaboration Center), Cytiva Asia-Pacific Fast Trak Center, and Thermo Fisher Bioprocess Design Center.


Songdo’s biopharmaceutical production capacity stands at 1.04 million liters per year (based on construction starts), ranking first among single cities worldwide. If the planned expansion of Samsung Biologics’ plant and the construction of Lotte Biologics’ plant proceed as scheduled, Songdo’s biopharmaceutical production capacity is expected to reach 2.14 million liters by 2030.


Yoon Wonseok, Commissioner of the Incheon Free Economic Zone Authority, stated, “The opening of the center marks an important starting point for Incheon to emerge as the center of bio innovation in Korea. We will do our utmost to help Incheon become a global bio innovation hub, based on our talent development programs and industrial infrastructure.”



Yoo Jeongbok, Mayor of Incheon, urged, “I hope the center will serve as a bridge connecting education, research, and industry, and lead Incheon to become a key hub for nurturing global bio talent.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing